Literature DB >> 17719209

Prevention of primary bacteraemia.

Antoni Juan-Torres1, Stephan Harbarth.   

Abstract

This overview provides information on recent advances in the prevention of primary bacteraemia, commonly defined as bloodstream infection without a documented source of infection, but including those resulting from an intravenous or arterial line infection. The potential to prevent community-acquired, primary bacteraemia is still limited and may be targeted mainly at vaccines for high-risk groups. In contrast, the prevention of catheter-related bacteraemia has seen substantial progress within the last 10 years. Consequently, intravascular device-related bacteraemia has become largely preventable under routine working conditions. Independent of the use of antibiotic-coated catheters, the implementation of clinical pathways and multimodal preventive strategies directed at several risk factors of catheter-related bacteraemia is a successful strategy to reduce this potentially life-threatening infection and deserves future health services research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719209     DOI: 10.1016/j.ijantimicag.2007.06.021

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

1.  Frictional properties of light-activated antimicrobial polymers in blood vessels.

Authors:  Polina Prokopovich; Stefano Perni; Clara Piccirillo; Jonathan Pratten; Ivan P Parkin; Michael Wilson
Journal:  J Mater Sci Mater Med       Date:  2009-09-27       Impact factor: 3.896

2.  An investigation of microbial adhesion to natural and synthetic polysaccharide-based films and its relationship with the surface energy components.

Authors:  Polina Prokopovich; Stefano Perni
Journal:  J Mater Sci Mater Med       Date:  2008-08-20       Impact factor: 3.896

Review 3.  Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?

Authors:  Arash Afshari; Jacques Schrenzel; Margareta Ieven; Stephan Harbarth
Journal:  Crit Care       Date:  2012-05-29       Impact factor: 9.097

4.  Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients.

Authors:  A Khorshidi; Ar Sharif
Journal:  Iran J Public Health       Date:  2010-06-30       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.